KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -81.2% | 10,300 | -78.4% | 0.00% | -85.7% |
| Q1 2016 | $223,000 | -36.3% | 47,664 | -31.3% | 0.01% | -17.6% |
| Q4 2015 | $350,000 | +297.7% | 69,376 | +176.0% | 0.02% | +325.0% |
| Q3 2015 | $88,000 | -22.1% | 25,140 | +122.5% | 0.00% | 0.0% |
| Q2 2015 | $113,000 | -86.1% | 11,300 | -82.3% | 0.00% | -87.5% |
| Q1 2015 | $814,000 | +150.5% | 63,937 | +235.4% | 0.03% | +39.1% |
| Q1 2014 | $325,000 | -26.8% | 19,062 | -56.6% | 0.02% | -34.3% |
| Q3 2013 | $444,000 | – | 43,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |